Zafgen

Zafgen Finally Speaks About Stock Plunge, But Says Nothing
TheStreet.com
Wed, 10/14/15 - 09:56 am
Zafgen
Zafgen Cancels Meetings, Investors Fear the Worst
TheStreet.com
Mon, 10/12/15 - 04:30 pm
Zafgen
Biogen And Four Other Biotech Stocks Worth Watching
Forbes
Sat, 10/10/15 - 09:12 am
Biogen
Esperion
Zafgen
Clovis Oncology
Portola
Zafgen Completes Enrollment of Phase 2b Trial of Beloranib in Severe Obesity Complicated by Type 2 Diabetes
Yahoo
Wed, 09/9/15 - 08:05 am
Zafgen
beloranib
clinical trials
obesity
diabetes
Zafgen Announces New Weight Loss and Safety Data from Phase 2 Trial of Beloranib in Hypothalamic Injury Associated Obesity at ENDO 2015
Yahoo
Sun, 03/8/15 - 10:18 am
Zafgen
hypothalamic injury-associated obesity
beloranib
Booming biotechs bank $2.7B in follow-on cash
Fierce Biotech
Fri, 01/23/15 - 03:38 pm
biotech
Prosensa
Biomarin
Zafgen
Alnylam
Auspex
Puma Biotechnology
Arena Pharmaceuticals
Radius Health
Intrexon
Zafgen's promising obesity drug comes through in another midstage trial
Fierce Biotech
Wed, 01/7/15 - 09:23 am
Zafgen
obesity
beloranib
hypothalamic injury-associated obesity
2014's most successful biotech IPOs
Fierce Biotech
Mon, 10/13/14 - 08:03 am
IPOs
biotech
Ultragenyx
ZS Pharma
Auspex Pharmaceuticals
Avalanche Biotechnologies
SAGE Therapeutics
Kite Pharma
Otonomy
Zafgen
ProQR
Radius Health
You’ve got obesity all wrong: Zafgen CEO
CNBC
Tue, 08/19/14 - 01:44 pm
obesity
Zafgen
Pharma CEOs
beloranib
Framing Up Capital Efficiency In Early Stage Biotech
Forbes
Thu, 07/17/14 - 09:18 am
biotech
capital efficiency
Zafgen
IPOs
Agios
Zafgen Supersizes Its Obesity-Focused IPO: An Early Investor's Reflections
Forbes
Wed, 06/25/14 - 07:44 am
Zafgen
obesity
IPOs
The Future of Fat Fighting: Next-Gen Obesity Drugs
Motley Fool
Sun, 05/25/14 - 10:30 am
obesity
weight loss
Zafgen
beloranid
Arena
Vivus
Qsymia
Belviq
Zafgen Opens A New Front In Its Obesity Strategy: Prader-Willi Syndrome
Forbes
Thu, 01/16/14 - 09:27 am
obesity
Zafgen
Prader-Willi Syndrome
beloranib
The Weight Loss Drug Company Investors Need to Watch Out For
Motley Fool
Fri, 12/13/13 - 08:32 am
beloranib
Zafgen
Vivus
Arena Pharmaceuticals
Zafgen drug helps patients lose up to 24 pounds
Yahoo/Reuters
Fri, 11/15/13 - 08:42 am
Zafgen
beloranib
obesity
New entrant in obesity drug race targets body, not the mind
Reuters
Sat, 08/24/13 - 11:35 am
Zafgen
obesity
weight loss. Beloranib
Zafgen Says Obesity Drug Spurs Weight Loss in Study
Bloomberg
Sun, 06/23/13 - 11:07 am
Zafgen
obesity
weight loss
beloranib
And the Obesity Plot Thickens
Motley Fool
Wed, 01/2/13 - 11:58 am
obesity
Vivus
Arena Pharmaceuticals
Roche
Orexigen
mimAb1
Amgen
Zafgen
Belviq
Qsymia
beloranib
Contrave
Obesity Drugs Gain Attention on FDA Backing for Therapies
Bloomberg
Wed, 09/19/12 - 10:53 am
FDA
obesity
Zafgen
beloranib
Arena Pharmaceuticals
Zafgen Announces Cardiovascular Data from Phase 1b Study of ZGN-433 in Obesity at American Diabetes Association Annual Meeting
Enhanced Online News
Sat, 06/25/11 - 11:25 am
Zafgen
ZGN-433
obesity
weight loss

Pages